
Swizip 4000mg/500mg Injection
Marketer
Swizing Biosciences
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Swizip 4000mg/500mg Injection
Combiflox 4000mg/500mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical practitioners, the dosage and frequency are determined by your physician based on your condition's severity. Strict adherence to prescribed usage is crucial. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (pain, swelling, redness). Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, inform your doctor of any antibiotic allergies, liver or kidney impairments; dosage adjustments or alternative medications may be necessary. Generally considered safe during pregnancy and lactation under strict medical guidance.
Primary Ingredients of Swizip 4000mg/500mg Injection
There is no text provided to rephrase.
Uses of Swizip 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Swizip 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Swizip 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Swizip 4000mg/500mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Swizip 4000mg/500mg Injection works:
The injectable formulation Swizip (4000mg/500mg Piperacillin/Tazobactam) unites two active agents. Piperacillin, an antibiotic, disrupts bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Piperacillin's antimicrobial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Swizip 4000mg/500mg Injection does not interact negatively with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable formulation Swizip, 4000mg/500mg, is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation is not contraindicated with Swizip 4000mg/500mg Injection. Research in humans indicates negligible drug transfer to breast milk, posing no identified risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Swizip 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with impaired kidney function, administration of Swizip 4000mg/500mg Injection requires careful consideration. Dosage modification of Swizip 4000mg/500mg Injection may be necessary. Medical advice should be sought.
LiverSAFE IF PRESCRIBED
The use of Swizip 4000mg/500mg Injection in patients with hepatic impairment is likely safe. Preliminary findings indicate that dosage modification may be unnecessary in this population. However, physician consultation is recommended.
What if you forget to take Swizip 4000mg/500mg Injection :
Should you omit a scheduled dose of Swizip 4000mg/500mg Injection, seek advice from your physician.
Facts to Know About Swizip 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
